📚 Module Overview
On completion of this module, you will be able to:
- Interpret non-fasting and fasting lipid profiles, identifying different levels of hypertriglyceridemia.
- Describe the management pathways for raised triglycerides based on UK guidance.
- Identify common secondary causes of hyperlipidaemia.
- Outline the pharmacology of key lipid-modifying drugs, including statins and fibrates.
- Recognise the urgency of managing severe hypertriglyceridemia (≥20 mmol/L).
- Confidently counsel patients on lifestyle changes and medication for managing hyperlipidaemia.
🗺️ Visual Management Pathway
The following flowchart provides a high-level overview of the management of hypertriglyceridemia in UK clinical practice. Subsequent sections of this module will explore each part of the pathway in detail.
🧭 Management Pathways Explained
Management is stratified based on the triglyceride level. The initial measurement is typically a non-fasting lipid profile.
Pathway 1: Triglycerides 2.3 to 9.9 mmol/L (Non-fasting)
- Assess for secondary causes: Before initiating treatment, it's crucial to identify and manage any underlying causes (see next section).
- Estimate CVD Risk: Use the QRISK3 tool to calculate the 10-year risk of developing cardiovascular disease.
- Treatment Decision:
- CVD Risk ≥ 10%: Offer a statin for primary prevention (see Pharmacology).
- CVD Risk < 10%: Focus on managing secondary causes and intensive lifestyle modification. A statin is not routinely offered unless there are other compelling reasons (e.g., strong family history, high-risk conditions not captured by QRISK3).
- Follow-up for Triglycerides ≥ 4.5 mmol/L: If, after addressing secondary causes and optimising statin therapy, the triglyceride level remains ≥ 4.5 mmol/L, NICE suggests considering a fibrate in addition to the statin, but this is often a specialist decision due to increased myopathy risk.
Pathway 2: Triglycerides 10 to 19.9 mmol/L (Non-fasting)
- Repeat with a FASTING sample: Recheck the lipid profile after a 12-hour fast, ideally within 2 weeks, to get a more accurate triglyceride level.
- Address secondary causes: This is a priority. Poorly controlled diabetes and excessive alcohol are common culprits.
- Treatment:
- Offer a statin for primary prevention (as CVD risk is inherently high).
- If fasting triglycerides remain high, referral to a lipid specialist should be considered. They may initiate a fibrate.
This constitutes a medical urgency due to the high risk of acute pancreatitis.
Action: Arrange urgent referral to a lipid specialist for assessment and management. This may involve admission to hospital. The primary goal is to rapidly lower triglycerides to prevent pancreatitis, often using fibrates and sometimes insulin infusions, alongside addressing any obvious secondary causes.
🔍 Common Secondary Causes of Hyperlipidaemia
Always consider and address these factors before attributing high lipids to a primary (genetic) cause. The mnemonic LIPIDS can be helpful:
- Lifestyle: High intake of alcohol, refined carbohydrates, and saturated fats; obesity; sedentary lifestyle.
- Iatrogenic (Drugs): Thiazide diuretics, beta-blockers, atypical antipsychotics, corticosteroids, oral oestrogens, some antiretrovirals.
- Pathology (Disease States):
- Endocrine: Poorly controlled diabetes mellitus, hypothyroidism.
- Renal: Nephrotic syndrome, chronic kidney disease.
- Hepatic: Cholestatic liver disease.
- Inflammation: Acute pancreatitis itself can raise triglycerides.
- Diet: As above.
- Smoking: Contributes to overall CVD risk.
💊 Pharmacological ManagementNICE NG238BNF
Drug therapy is aimed at reducing cardiovascular risk and, in severe cases, preventing pancreatitis.
Statins (HMG-CoA Reductase Inhibitors)
Statins are first-line for primary and secondary prevention of CVD. They primarily lower LDL-cholesterol but also have a modest triglyceride-lowering effect.
| Treatment Line | Medication & Dosage | Monitoring & Key Alerts |
|---|---|---|
| First-Line (Primary Prevention) |
Atorvastatin 20mg OD
|
Monitoring:
|
| Secondary Prevention / Dose Titration |
Atorvastatin 80mg OD
|
Monitoring and alerts as above. Higher dose increases the risk of side effects. If intolerant, consider switching to another statin (e.g., Rosuvastatin). |
Fibrates
Fibrates are primarily used to lower triglycerides. Their role in CVD prevention as monotherapy is less clear than statins.
| Indication | Medication & Dosage | Monitoring & Key Alerts |
|---|---|---|
| Severe Hypertriglyceridemia |
Fenofibrate (various brands/doses, e.g., 200mg OD or 267mg OD)
|
Monitoring:
|
| Adjunct to Statin |
Fenofibrate
|
Other Agents
Icosapent Ethyl: A highly purified omega-3 fatty acid, licensed as an adjunct to statin therapy for patients with established CVD and raised triglycerides (≥1.7 mmol/L).
Ezetimibe: Primarily lowers LDL-C by inhibiting cholesterol absorption. Used if statins are not tolerated or if lipid targets aren't met on a maximal statin dose.
🥗 Lifestyle Advice & Support Services
Lifestyle modification is the cornerstone of managing hyperlipidaemia.
🥑 Diet & Nutrition
Focus on reducing intake of alcohol, sugar, and refined carbohydrates, and replacing saturated fats with unsaturated fats.
- NHS Eat Well Guide: Provides general principles of a healthy, balanced diet.
- British Heart Foundation: Excellent resources on heart-healthy eating, including specific advice on managing cholesterol.
- Heart UK: The UK's cholesterol charity, offering detailed dietary advice and patient support.
🏃 Physical Activity
Aim for at least 150 minutes of moderate-intensity activity (like brisk walking) or 75 minutes of vigorous-intensity activity (like running) per week.
- NHS Get Active: Provides tools, apps (like Couch to 5K), and advice to help people become more active.
🍺 Alcohol Reduction
Alcohol is a major contributor to high triglycerides. Advise patients to stay within the recommended limit of 14 units per week, with several drink-free days.
- Drinkaware: Offers tools to track units and advice for cutting down.
- NHS Drink Less: Provides strategies and support for reducing alcohol intake.
🎯 OSCE Preparation
Counselling a Patient Starting Atorvastatin
Scenario: Mrs. Jones, 58, has a QRISK3 score of 15%. Her non-fasting lipids are: Total Chol 6.2, HDL 1.1, non-HDL 5.1, Triglycerides 2.5. You need to counsel her on starting Atorvastatin 20mg.
Key Counselling Steps:- Explain the 'Why': "Your recent check-up showed you have a higher chance of having a heart attack or stroke in the next 10 years. This tablet, Atorvastatin, is very effective at lowering that risk."
- Explain the 'How': "It works by reducing the amount of 'bad' cholesterol your body makes. This helps to keep your blood vessels healthy."
- Address Key Side Effects (The 'Muscle' Talk): "The most important thing to be aware of is muscle pain. Most people have no problems, but if you get any muscle aches or pains that you can't explain, please let us know straight away."
- Explain Monitoring: "We'll need to do a blood test before you start and another one in 3 months to check it's working well and that your liver is happy with the new medicine."
- Reinforce Lifestyle: "This tablet works best alongside a healthy lifestyle. Continuing with a balanced diet and regular walks will give you the most benefit."
- Check Understanding (Teach-Back): "To make sure I've explained it clearly, could you tell me what side effect you need to look out for?"
⭐ Bonus: Clinical Pharmacist Case Study
The Patient: Managing Severe Hypertriglyceridemia
Patient Profile: Mr. Singh, a 45-year-old taxi driver with type 2 diabetes, presents for a medication review. He mentions having a few episodes of upper abdominal pain recently. He drinks "a fair bit" of whisky in the evenings.
Current Medications: Metformin 1g BD, Gliclazide 80mg BD.
Recent Bloods: HbA1c 88 mmol/mol. A non-fasting lipid profile was taken: Triglycerides 22.5 mmol/L, Cholesterol 9.8 mmol/L.
Pharmacist's Assessment & Plan (SOAP Note Format)
- Subjective: Patient reports intermittent epigastric pain. Admits to significant alcohol intake. Seems unaware of the seriousness of his results.
- Objective: HbA1c 88 (very poor control). Triglycerides 22.5 mmol/L (critically high).
- Assessment:
- Severe Hypertriglyceridemia: Level >20 mmol/L puts him at immediate high risk of life-threatening acute pancreatitis. The abdominal pain may be an early warning sign.
- Likely Secondary Causes: The high triglycerides are almost certainly driven by a combination of 1) very poorly controlled diabetes and 2) excessive alcohol consumption.
- Plan:
- Urgent Action: This is a clinical emergency. Contact the on-call medical registrar or lipid specialist at the local hospital for immediate advice and to arrange an urgent assessment. He will likely need admission.
- Immediate Patient Advice (while awaiting specialist input):
- Alcohol: Advise complete and immediate cessation of all alcohol. Explain clearly that alcohol is like "pouring fuel on the fire" for his triglycerides and pancreatitis risk.
- Diet: Advise a very low-fat diet immediately.
- Safety Netting: Explain that if his abdominal pain becomes severe or constant, he must go to A&E immediately.
- Diabetes Management: His diabetes control is a major driver and needs urgent optimisation. This will likely involve starting insulin, which is a decision for the hospital/diabetes team.
- Communication: Clearly document the conversation, the plan, and the communication with the secondary care team in the patient's record. Inform his named GP of the urgent action taken.